We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
27 June 2018
On April 10 2018 Health Canada issued a notice of intent to "propose regulatory changes to strengthen the post-market surveillance and risk management of medical devices in Canada". The intended amendments are to reflect changes made to the Food and Drugs Act following the enactment of the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law). The proposed changes will, among other things, provide the minister of health with the authority to:
Health Canada intends to pre-publish the proposed regulatory amendments in 2019.
For further information on this topic please contact Andrew Mandlsohn at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (firstname.lastname@example.org). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.